Literature DB >> 19881424

The Joint Admission Medical Program: a statewide approach to expanding medical education and career opportunities for disadvantaged students.

Bernell Dalley1, Alan Podawiltz, Robert Castro, Kathleen Fallon, Marylee Kott, Jeffrey Rabek, James Richardson, William Thomson, Pamela Ferry, Budge Mabry, Paul Hermesmeyer, Quentin Smith.   

Abstract

In 2003, Texas initiated an experiment to address enrollment disparities in its medical schools. With bipartisan support from key Texas legislators, funding was allocated in 2002 to establish the Joint Admission Medical Program (JAMP). Texas' then eight medical schools created, through JAMP, a partnership with the state's 31 public and 34 private undergraduate colleges and universities. Cognizant of legal prohibitions against reliance solely on race or ethnicity in promoting diversity, JAMP is designed to enhance opportunities for economically disadvantaged students from across the state, including those from (1) rural and remote areas of the state, and (2) institutions that have historically sent few students to medical school. Now in its seventh year of operation, JAMP is overseen by a council with representatives from all nine Texas medical schools. For the six years-2003 to 2008-for which data are available, indicators of JAMP performance can be seen in (1) the numbers of applicants to JAMP (1,230 applicants in the first six years), (2) levels of JAMP participation (480 participants), and (3) matriculation of JAMP participants into medical schools (164 of 288 of those accepted into the program in the years 2003-2006).The authors provide a brief history of JAMP, describe its structure and operation, summarize objective performance data, and identify some of the challenges still faced. These include increasing the participation of students from underrepresented minority groups within the legal structure for the program, and fostering substantive participation in JAMP by all of Texas' undergraduate institutions. A focused effort is under way to strengthen the evaluative aspects of JAMP so that more comprehensive data, including subjective evaluation data from participants, can be shared with colleagues in the future.

Entities:  

Mesh:

Year:  2009        PMID: 19881424     DOI: 10.1097/ACM.0b013e3181b6c76b

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  6 in total

1.  Creating an MCH Pipeline for Disadvantaged Undergraduate Students.

Authors:  Alice A Kuo; Bobby Verdugo; Faye J Holmes; Katherine A Henry; Julie H Vo; Victor H Perez; Moira Inkelas; Alma D Guerrero
Journal:  Matern Child Health J       Date:  2015-10

2.  Speaking out about gender imbalance in invited speakers improves diversity.

Authors:  Robyn S Klein; Rhonda Voskuhl; Benjamin M Segal; Bonnie N Dittel; Thomas E Lane; John R Bethea; Monica J Carson; Carol Colton; Susanna Rosi; Aileen Anderson; Laura Piccio; Joan M Goverman; Etty N Benveniste; Melissa A Brown; Seema Kaushalya Tiwari-Woodruff; Tajie H Harris; Anne H Cross
Journal:  Nat Immunol       Date:  2017-04-18       Impact factor: 25.606

3.  Nature of association between rural background and practice location: a comparison of general practitioners and specialists.

Authors:  Matthew R McGrail; John S Humphreys; Catherine M Joyce
Journal:  BMC Health Serv Res       Date:  2011-03-23       Impact factor: 2.655

4.  Male physicians treating Female patients: Issues, Controversies and Gynecology.

Authors:  Jacques Balayla
Journal:  Mcgill J Med       Date:  2011-06

5.  Are Women Proportionately Represented as Speakers at Orthopaedic Surgery Annual Meetings? A Cross-Sectional Analysis.

Authors:  Katherine M Gerull; Dongyeon J Kim; Taylor Cogsil; Lee Rhea; Cara Cipriano
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

6.  Medical students' views on the value of trigger warnings in education: A qualitative study.

Authors:  Helen A Nolan; Lesley Roberts
Journal:  Med Educ       Date:  2022-04-08       Impact factor: 7.647

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.